Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU4-56P (RNA, U4 small nuclear 56, pseudogene) is a non-functional genetic element categorized as a pseudogene within the U4 small nuclear RNA family. The functional U4 snRNA is essential for pre-mRNA splicing as part of the spliceosome, but RNU4-56P itself does not encode a functional RNA and has no known biological role, disease association, or relevance to drug targets. This locus exists in the genome likely as a remnant of evolutionary duplication and has not been implicated in human disease or therapy[1][3]. Important clarification: Much of the research and disease relevance attaches to functional U4 snRNA genes (such as RNU4-2), which is highly expressed in brain and whose variants are associated with neurodevelopmental disorders[2][3]. RNU4-56P is distinct, lacks function, and is not synonymous with RNU4-2 or other functional U4 genes. Information regarding splicing, disease, and drug interaction reported in the literature pertains to functional U4 snRNA, not to pseudogenes like RNU4-56P[1][3]. If you seek functional, disease-associated molecules, consider RNA, U4 small nuclear 2 (RNU4-2) rather than the non-coding, non-functional RNU4-56P.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 56, pseudogene (RNU4-56P).